<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.healthnewspapers.com/science/zosurabalpin-crab-acinetobacter-in-vitro</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>A first-in-class antibiotic held its edge against resistant Acinetobacter</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/vla15-lyme-vaccine-booster-phase-2</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>A Lyme vaccine&apos;s second yearly booster held up in a phase 2 trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/h5n1-oseltamivir-resistant-d1-1-british-columbia</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>An oseltamivir-resistant H5N1 turned up on farms with no drug pressure</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/enhance-magrolimab-azacitidine-mds</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>ENHANCE: magrolimab added toxicity but no benefit in higher-risk MDS</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/covid-2025-2026-vaccine-effectiveness-older-adults</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>Updated COVID shots cut hospitalisation in over-65s, interim data show</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/acoustic-slow-wave-sleep-memory-closed-loop-crossover</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>Sounds played during deep sleep improved memory in a small crossover trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/mind/mirtazapine-methamphetamine-use-disorder-phase-3-trial</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>Mirtazapine modestly cut methamphetamine use in an Australian phase 3 trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/mind/latam-fingers-multidomain-lifestyle-cognitive-decline</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>A structured lifestyle programme beat health advice for cognition in Latin America</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/mind/ecopipam-tourette-syndrome-phase-3-randomised-withdrawal</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>Ecopipam cut relapse risk in children with Tourette syndrome in a phase 3 trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/traditional-food-markets-pathogen-prevalence-meta-analysis</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>Pathogens turn up in one in six samples from traditional food markets, review finds</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/dose-sparing-ipv-infants-india-trial</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>A quarter-dose polio shot made in India matches full IPV in an infant trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/curavivax-dha-piperaquine-chloroquine-brazil</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>In the Amazon, an artemisinin combination outperforms chloroquine for vivax malaria</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/bundibugyo-ebola-seventh-province-7890-cases</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>DRC&apos;s Bundibugyo Ebola outbreak reaches a seventh province and 7,890 cases</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/morphine-dilaudid-simplist-syringe-recall</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>Fresenius Kabi recalls morphine syringes that actually contain hydromorphone</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/garetosmab-pasatru-fop-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>FDA approves garetosmab for fibrodysplasia ossificans progressiva</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/epinephrine-injection-recall-sterility</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>American Regent recalls injectable epinephrine over particulate matter and leaking vials</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/apitegromab-isembyld-sma-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-29</news:publication_date>
      <news:title>FDA approves apitegromab, a myostatin inhibitor, for spinal muscular atrophy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/skyscraper-01-tiragolumab-nsclc-null</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-28</news:publication_date>
      <news:title>SKYSCRAPER-01 confirms tiragolumab added nothing in PD-L1-high lung cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/champion-af-appendage-closure-versus-anticoagulation</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-27</news:publication_date>
      <news:title>Appendage closure matched anticoagulation in the industry-funded CHAMPION-AF trial</news:title>
    </news:news>
  </url>
</urlset>